Lorenzo Scalise
Overview
Explore the profile of Lorenzo Scalise including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abo Alzahab N, Di Iorio A, Apollonio L, Alshalak M, Gravina A, Antognoli L, et al.
Data Brief
. 2024 Nov;
57:111065.
PMID: 39583262
This work aims to assess the use of electroencephalographic (EEG) signals as a means of biometric authentication. More than 240 recordings, each lasting 2 min, were gathered from 20 subjects...
2.
Spriano F, Tarantelli C, Cascione L, Gaudio E, Golino G, Scalise L, et al.
Br J Haematol
. 2024 Jul;
205(5):1873-1882.
PMID: 39080847
Camidanlumab tesirine (ADCT-301) is a CD25-specific antibody-drug conjugate (ADC) employing SG3199, a highly cytotoxic DNA minor groove cross-linking pyrrolobenzodiazepine dimer. The ADC has shown early clinical antitumour activity in various...
3.
Meletani S, Scataglini S, Mandolini M, Scalise L, Truijen S
Sensors (Basel)
. 2024 Jul;
24(14).
PMID: 39066067
(1) Background: Traditional gait assessment methods have limitations like time-consuming procedures, the requirement of skilled personnel, soft tissue artifacts, and high costs. Various 3D time scanning techniques are emerging to...
4.
Tarantelli C, Wald D, Munz N, Spriano F, Bruscaggin A, Cannas E, et al.
Haematologica
. 2024 May;
109(10):3314-3326.
PMID: 38721745
Antibody-drug conjugates (ADC) represent one of the most successful therapeutic approaches introduced into clinical practice in the last few years. Loncastuximab tesirine (ADCT-402) is a CD19-targeting ADC in which the...
5.
Ferroni G, Sabeti S, Abdus-Shakur T, Scalise L, Carter J, Fazzio R, et al.
Breast Cancer Res
. 2023 Jun;
25(1):65.
PMID: 37296471
Purpose: Changes in microcirculation of axillary lymph nodes (ALNs) may indicate metastasis. Reliable noninvasive imaging technique to quantify such variations is lacking. We aim to develop and investigate a contrast-free...
6.
Heat Generation During Initial Osteotomy for Implant Site Preparation: An In Vitro Measurement Study
Aquilanti L, Antognoli L, Rappelli G, Di Felice R, Scalise L
J Maxillofac Oral Surg
. 2023 May;
22(2):313-320.
PMID: 37122802
Introduction: Controlling temperature generation during implant site preparation is important to prevent implant early failure. Aim: The present in vitro study aimed at measuring temperature variation generated during the initial...
7.
Kurti M, Sabeti S, Robinson K, Scalise L, Larson N, Fatemi M, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980774
Low specificity in current ultrasound modalities for thyroid cancer detection necessitates the development of new imaging modalities for optimal characterization of thyroid nodules. Herein, the quantitative biomarkers of a new...
8.
Cosoli G, Antognoli L, Scalise L
Biosensors (Basel)
. 2023 Feb;
13(2).
PMID: 36831919
Wearable devices are rapidly spreading thanks to multiple advantages. Their use is expanding in several fields, from medicine to personal assessment and sport applications. At present, more and more wearable...
9.
Lucchetta D, Castellini P, Martarelli M, Scalise L, Pandarese G, Riminesi C, et al.
Materials (Basel)
. 2023 Jan;
16(2).
PMID: 36676299
In this work, we study the light-induced changes of the rotational speed of a thin photomobile film using a single-axis acoustic levitator operating at 40 kHz. In our experiments, a...
10.
Spriano F, Sartori G, Tarantelli C, Barreca M, Golino G, Rinaldi A, et al.
EJHaem
. 2022 Sep;
3(3):764-774.
PMID: 36051080
Inhibitors of the Bromo- and Extra-Terminal domain (BET) family proteins have strong preclinical antitumor activity in multiple tumor models, including lymphomas. Limited single-agent activity has been reported in the clinical...